Cel-Sci (CVM) Stock: Buy, Sell, or Hold?
$1.59
+0.31 (+24.22%)
▲
5d:
+17.78%
30d:
-11.17%
90d:
+0.0%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (92%)
Quality Score
56/100
Position
FAIR
30-Day Fair Range
$1.36 – $1.75
Position: FAIR
Forward P/E & Valuation
-0.2x
Next 12M consensus est.
Wall Street Target
$12.50
+876.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.15 / $1.53
Trend: Correction / Pullback
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: CVM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When CVM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CVM is currently trading at $1.59, which is considered fair relative to its 30-day fair value range of $1.36 to $1.75.
Technical Outlook: Technically, CVM is showing correction / pullback momentum. The price is approaching resistance at $1.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 24.2% recently.
Market Sentiment: CVM scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.50 (+876.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CVM is showing correction / pullback momentum. The price is approaching resistance at $1.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 24.2% recently.
Market Sentiment: CVM scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.50 (+876.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.36 -
$1.75
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
Trading Range & Key Levels
30-Day Trading Range
$1.36 -
$1.75
Current vs Trading Range
FAIR
Support Level
$1.15
Resistance Level
$1.53
Current Trend
Correction / Pullback
Technical data as of
Nov 13, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
29d (50% conf)
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+24.2%)
- BULLISH: Trading 876.6% below Wall St target ($12.50)
- BULLISH: Bottoming setup score 60/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-0.20
Wall Street Target
$12.50
(+876.6%)
Revenue Growth (YoY)
-62.7%
Share CVM Analysis
Share this live CVM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CVM)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary:
CEL-SCI presented new Phase 3 Multikine data at the World Congress, identifying a significant increase in pre-surgical response and substantial overall survival advantage for head neck cancer patients with specific biomarkers.
Key Retail Themes:
pre-surgical response
overall survival advantage
safety profile
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 2:01 PM ET
Data refreshes hourly during market hours. Next update: 3:01 PM
Data refreshes hourly during market hours. Next update: 3:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$275 | 44 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 39 SELL |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 45 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 54 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CVM Research Pages
CVM Technical Chart
CVM Price Prediction
CVM Intrinsic Value DCF
CVM Earnings Date
Why is CVM Moving Today?
CVM Investment Advisor
CVM Fair Price Analyzer
CVM Target Price Playground
CVM LEAP Simulator
CVM Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
CVM Competitors
Part B: Tradestie Flagship Market Scanners